Profil
Eyal Kalo is currently Director-Research & Development at InnoCan Pharma Corp.
since 2023.
Formerly, Dr. Kalo was Chief Technology Officer at eSense-Lab Ltd. from 2017 to 2022.
Education includes a doctorate from Weizmann Institute of Science conferred in 2010 and an undergraduate degree from Bar-Ilan University.
Aktive Positionen von Eyal Kalo
| Unternehmen | Position | Beginn |
|---|---|---|
| INNOCAN PHARMA CORPORATION | Technik-/Wissenschafts-/F&E-Leiter | 01.05.2023 |
Ehemalige bekannte Positionen von Eyal Kalo
| Unternehmen | Position | Ende |
|---|---|---|
| ESENSE-LAB LTD | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2022 |
Ausbildung von Eyal Kalo
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Bar-Ilan University
Bar-Ilan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Weizmann Institute of Science
Weizmann Institute of Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
eSense-Lab Ltd.
eSense-Lab Ltd. BiotechnologyHealth Technology Operates technology, research and development pharmaceutical company | Health Technology |
InnoCan Pharma Corp.
InnoCan Pharma Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
















